These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Virtual Screening Approach of Bacterial Peptide Deformylase Inhibitors Results in New Antibiotics. Merzoug A; Chikhi A; Bensegueni A; Boucherit H; Okay S Mol Inform; 2018 Mar; 37(3):. PubMed ID: 28991412 [TBL] [Abstract][Full Text] [Related]
23. Antibacterial activity of xylose-derived LpxC inhibitors - Synthesis, biological evaluation and molecular docking studies. Dreger A; Hoff K; Agoglitta O; Hotop SK; Brönstrup M; Heisig P; Kirchmair J; Holl R Bioorg Chem; 2021 Feb; 107():104603. PubMed ID: 33429229 [TBL] [Abstract][Full Text] [Related]
24. Bacterial Peptide deformylase inhibition of cyano substituted biaryl analogs: Synthesis, in vitro biological evaluation, molecular docking study and in silico ADME prediction. Khan FA; Patil RH; Shinde DB; Sangshetti JN Bioorg Med Chem; 2016 Aug; 24(16):3456-63. PubMed ID: 27269198 [TBL] [Abstract][Full Text] [Related]
25. Theoretical study of Escherichia coli peptide deformylase inhibition by several drugs. Chikhi A; Bensegueni A; Boulahrouf A; Bencharif M In Silico Biol; 2006; 6(5):459-66. PubMed ID: 17274774 [TBL] [Abstract][Full Text] [Related]
26. Slow-binding inhibition of peptide deformylase by cyclic peptidomimetics as revealed by a new spectrophotometric assay. Nguyen KT; Hu X; Pei D Bioorg Chem; 2004 Jun; 32(3):178-91. PubMed ID: 15110195 [TBL] [Abstract][Full Text] [Related]
27. N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity. Hackbarth CJ; Chen DZ; Lewis JG; Clark K; Mangold JB; Cramer JA; Margolis PS; Wang W; Koehn J; Wu C; Lopez S; Withers G; Gu H; Dunn E; Kulathila R; Pan SH; Porter WL; Jacobs J; Trias J; Patel DV; Weidmann B; White RJ; Yuan Z Antimicrob Agents Chemother; 2002 Sep; 46(9):2752-64. PubMed ID: 12183225 [TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological evaluation of potent FAAH inhibitors. Tuo W; Leleu-Chavain N; Barczyk A; Renault N; Lemaire L; Chavatte P; Millet R Bioorg Med Chem Lett; 2016 Jun; 26(11):2701-5. PubMed ID: 27117424 [TBL] [Abstract][Full Text] [Related]
29. The Discovery of Antibacterial Natural Compound Based on Peptide Deformylase. Liang L; Zhou Q; Hao Z; Wang F; Zhu Y; Lin Q; Gao J Comb Chem High Throughput Screen; 2018; 21(4):292-297. PubMed ID: 29468960 [TBL] [Abstract][Full Text] [Related]
30. The evolution of peptide deformylase as a target: contribution of biochemistry, genetics and genomics. Yuan Z; White RJ Biochem Pharmacol; 2006 Mar; 71(7):1042-7. PubMed ID: 16289392 [TBL] [Abstract][Full Text] [Related]
31. [Peptide-deformylase inhibitors, a new class of antibiotics]. Dubreuil L Presse Med; 2002 Nov; 31(38):1810-2. PubMed ID: 12497724 [TBL] [Abstract][Full Text] [Related]
32. Acylprolinamides: a new class of peptide deformylase inhibitors with in vivo antibacterial activity. Axten JM; Medina JR; Blackledge CW; Duquenne C; Grant SW; Bobko MA; Peng T; Miller WH; Pinckney T; Gallagher TF; Kulkarni S; Lewandowski T; Van Aller GS; Zonis R; Ward P; Campobasso N Bioorg Med Chem Lett; 2012 Jun; 22(12):4028-32. PubMed ID: 22579486 [TBL] [Abstract][Full Text] [Related]
33. Structures of Staphylococcus aureus peptide deformylase in complex with two classes of new inhibitors. Lee SJ; Lee SJ; Lee SK; Yoon HJ; Lee HH; Kim KK; Lee BJ; Lee BI; Suh SW Acta Crystallogr D Biol Crystallogr; 2012 Jul; 68(Pt 7):784-93. PubMed ID: 22751663 [TBL] [Abstract][Full Text] [Related]
34. PDF inhibitors: an emerging class of antibacterial drugs. Johnson KW; Lofland D; Moser HE Curr Drug Targets Infect Disord; 2005 Mar; 5(1):39-52. PubMed ID: 15777197 [TBL] [Abstract][Full Text] [Related]